Everolimus tablets for patients with subependymal giant cell astrocytoma

Author： Turner Scott G Peters Katherine B Vredenburgh James J Desjardins Annick Friedman Henry S Reardon David A

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.14, 2011-10, pp. : 2265-2269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Everolimus: In Patients with Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex

By Curran Monique P.

Pediatric Drugs, Vol. 14, Iss. 1, 2012-02 ,pp. : 51-60

Adis International

Access to resources Recommend Favorite

Current Use of mTOR Inhibitors for the Treatment of Subependymal Giant Cell Astrocytomas and Epilepsy in Patients with TSC

Current Medicinal Chemistry, Vol. 23, Iss. 37, 2016-12 ,pp. : 4260-4269

Bentham Science Publishers

Access to resources Recommend Favorite

Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with Everolimus

By Massard Christophe Fizazi Karim Gross-Goupil Marine Escudier Bernard

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 879-881

Springer Publishing Company

Access to resources Recommend Favorite

Everolimus: In Advanced Renal Cell Carcinoma

By Garnock-Jones Karly P. Keating Gillian M.

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2115-2124

Adis International

Access to resources Recommend Favorite

Evaluation of everolimus in renal cell cancer

By Amato Robert Stepankiw Mika

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1229-1240

Informa Healthcare

Access to resources Recommend Favorite